sirolimus and Cytokine-Release-Syndrome

sirolimus has been researched along with Cytokine-Release-Syndrome* in 1 studies

Other Studies

1 other study(ies) available for sirolimus and Cytokine-Release-Syndrome

Article	Year
Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19. Clinical immunology (Orlando, Fla.), 2020, Volume: 216 Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Disease Progression; Gene Expression Regulation; Humans; Immunity, Innate; Immunologic Factors; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; SARS-CoV-2; Sirolimus; T-Lymphocytes	2020

Article

Year

Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19.

Clinical immunology (Orlando, Fla.), 2020, Volume: 216

Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Cytokines; Disease Progression; Gene Expression Regulation; Humans; Immunity, Innate; Immunologic Factors; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; SARS-CoV-2; Sirolimus; T-Lymphocytes

2020